From billionaire-backed biotech to promising animal studies, this early trial will test whether partial reprogramming can ...

St. Jude Children's Research Hospital scientists have discovered how tumors disable immune "gatekeeper" cells that alert the rest of the immune system to the presence of cancer—and how restoring their ...

“How old would you like to be when you die?” That’s the question my primary care physician asked during my routine physical. It’s a complex question, one without a right answer. As long as possible, ...

Radiotherapy (RT) is one of the most widely used cancer treatment modalities, applied in over half of all patients with cancer. In clinical oncology, positron emission tomography (PET) with 18 ...

Add Yahoo as a preferred source to see more of our stories on Google. Unlike typical glaucoma treatments that slow progression, this approach aims to rejuvenate the retinal ganglion cells that die ...

In our memory are such facts as: Albany is the capital of New York; Jefferson was the third president; summer follows spring; I attended Columbus School. These facts bring up no reaction in your body.

In a bid to treat blindness, Life Biosciences will try out potent cellular reprogramming technology on volunteers. When Elon Musk was at Davos last week, an interviewer asked him if he thought aging ...

Atomic defects in nanodiamonds enable both precise heating of lysosomes inside macrophages and nanoscale temperature measurement, revealing that localized thermal spikes trigger immune cell ...

New funding led by Goldcrest Capital and Godfrey Capital to advance lead candidate JUN_01 for type 2 diabetes and obesity to first-in-human studies JUN_01 would be the first ever candidate to ...